Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
作者:Hong C. Shen、Andrew K.P. Taggart、Larissa C. Wilsie、M. Gerard Waters、Milton L. Hammond、James R. Tata、Steven L. Colletti
DOI:10.1016/j.bmcl.2008.08.039
日期:2008.9
Pyrazolopyrimidines were discovered as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A. In addition to its intrinsic activity, compound 9n significantly enhances nicotinic acid binding to the receptor, thereby potentiating the functional efficacy of nicotinic acid.
发现吡唑并嘧啶是高亲和力烟酸受体GPR109A的第一类变构激动剂。除了其固有活性外,化合物9n还显着增强了烟酸与受体的结合,从而增强了烟酸的功能功效。